Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
British Journal of Cancer
|
May 1, 1996
Identification of leukaemic cells in bone marrow and blood samples by a new cytofluorometric assay
M Hengstschläger, M Pfeilstöcker, E Wawra
Advances in Experimental Medicine and Biology
|
May 23, 1998
Thymidine kinase expression. A marker for malignant cells
M Hengstschläger, M Pfeilstöcker, E Wawra
Infusionstherapie Und Transfusionsmedizin
|
August 1, 1995
[Experiences with anti-Rhesus-D therapy in pretreated patients with idiopathic thrombocytopenia]
M Pfeilstöcker, R Waldner, R Reisner, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
August 1, 1995
FMS hemizygosity in myeloid dysplasia and acute myeloid leukemia with chromosomal aberration del(5)(q) demonstrated by polymerase chain reaction
M Pfeilstöcker, R Grill, E Koller, et al.
Cancer Research
|
November 14, 1997
Association of human T-cell leukemia virus and myelodysplastic syndrome in a central European population
H Karlic, M Möstl, H Mucke, et al.
European Journal of Clinical Investigation
|
March 27, 2009
Deferasirox induces regression of iron overload in patients with myelodysplastic syndromes
F Wimazal, T Nösslinger, C Baumgartner, et al.
Leukemia Research
|
August 8, 2001
Dysplastic versus proliferative CMML--a retrospective analysis of 91 patients from a single institution
T Nösslinger, R Reisner, H Grüner, et al.
Stem Cells (Dayton, Ohio)
|
July 21, 2001
Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML)
H Karlic, N Louda, M Pfeilstöcker, et al.
Blood
|
November 8, 2001
Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution
T Nösslinger, R Reisner, E Koller, et al.
American Journal of Hematology
|
June 22, 2000
Hematopoietic recovery after IEV chemotherapy for malignant lymphoma followed by different cytokines can be monitored by analysis of Galpha 16 and CD34
M Pfeilstöcker, H Karlic, J Salamon, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
British Journal of Cancer
|
May 1, 1996
Identification of leukaemic cells in bone marrow and blood samples by a new cytofluorometric assay
M Hengstschläger, M Pfeilstöcker, E Wawra
Advances in Experimental Medicine and Biology
|
May 23, 1998
Thymidine kinase expression. A marker for malignant cells
M Hengstschläger, M Pfeilstöcker, E Wawra
Infusionstherapie Und Transfusionsmedizin
|
August 1, 1995
[Experiences with anti-Rhesus-D therapy in pretreated patients with idiopathic thrombocytopenia]
M Pfeilstöcker, R Waldner, R Reisner, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
August 1, 1995
FMS hemizygosity in myeloid dysplasia and acute myeloid leukemia with chromosomal aberration del(5)(q) demonstrated by polymerase chain reaction
M Pfeilstöcker, R Grill, E Koller, et al.
Cancer Research
|
November 14, 1997
Association of human T-cell leukemia virus and myelodysplastic syndrome in a central European population
H Karlic, M Möstl, H Mucke, et al.
European Journal of Clinical Investigation
|
March 27, 2009
Deferasirox induces regression of iron overload in patients with myelodysplastic syndromes
F Wimazal, T Nösslinger, C Baumgartner, et al.
Leukemia Research
|
August 8, 2001
Dysplastic versus proliferative CMML--a retrospective analysis of 91 patients from a single institution
T Nösslinger, R Reisner, H Grüner, et al.
Stem Cells (Dayton, Ohio)
|
July 21, 2001
Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML)
H Karlic, N Louda, M Pfeilstöcker, et al.
Blood
|
November 8, 2001
Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution
T Nösslinger, R Reisner, E Koller, et al.
American Journal of Hematology
|
June 22, 2000
Hematopoietic recovery after IEV chemotherapy for malignant lymphoma followed by different cytokines can be monitored by analysis of Galpha 16 and CD34
M Pfeilstöcker, H Karlic, J Salamon, et al.
Page
of 3